Key Insights

Highlights

Treatment Research

2 treatments under study, led by Lymecyclin And Corresponding Placebos Of The Experimental Arm

Research Leaders

5 sponsors active, led by Assistance Publique Hopitaux De Marseille

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05821478Phase 3Recruiting

Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients

Showing all 1 trials

Research Network

Common Treatments

  • Lymecyclin And Corresponding Placebos Of The Experimental Arm1
  • Rocephin Metronidazole Rifadin Izilox Placebo Combination Therapy1

Active Sponsors

  • Assistance Publique Hopitaux De Marseille1
  • Ministry of Health, France1
  • Institut Pasteur1
  • Centre Hospitalier Universitaire de Caen1
  • Hôpital Necker-Enfants Malades1

Top Investigators

Related Conditions

  • Hidradenitis Suppurativa1

Activity Timeline